...
首页> 外文期刊>Animal Pharm Weekly Briefing >Jeff Simmons next CEO to highlight consequences of ASF
【24h】

Jeff Simmons next CEO to highlight consequences of ASF

机译:下CEO杰夫·西蒙斯强调的后果ASF

获取原文
获取原文并翻译 | 示例
           

摘要

Elanco's Jeff Simmons has become the latest animal health leader to point out the growing impact African swine fever (ASF) is having on the industry.As trade negotiations have progressed, pork exports to China have become a more significant opportunity for US producers."As a result, many farmers are moving away from ractopamine products to enable access to the China market," Mr Simmons explained. "This impacts our swine product Paylean, which globally is less than 1% of our total sales."US investment bank William Blair recently suggested Paylean represents about 1% of Elanco's overall turnover. However, Mr Simmons' latest comments indicate the impact of the drop in ractopamine sales will have a smaller impact than William Blair's estimates.
机译:Elanco的杰夫·西蒙斯已经成为最新的动物卫生领导人指出越来越多的影响非洲猪瘟(ASF)是对的行业。猪肉对中国的出口已经成为更多重要的美国生产商的机会。因此,许多农民离开莱克多巴胺产品,使访问中国市场,”西蒙斯先生解释道。影响我们的猪产品Paylean,全球小于总销售额的1%。银行最近William Blair建议Paylean代表Elanco整体营业额的1%左右。然而,西蒙斯先生的最新评论指出莱克多巴胺的销售会下降的影响一个较小的影响比威廉·布莱尔的估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号